Intra-arterial administration of neuroprotective agents is named as a drug or biological intervention in 2 clinical trials in our China trial register, 2 of which are recruiting. The lead sponsor is Hui-Sheng Chen. Registered phase: Not applicable. Conditions studied include Ischemic Stroke; Neuroprotection; Stroke, Ischemic.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT04664933 | Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET) (ClinicalTrials.gov ↗) Stroke, Ischemic, Intravascular Thrombosis, Mechanical Thrombectomy |
Not applicable | Recruiting |
| NCT04664946 | Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT) (ClinicalTrials.gov ↗) Ischemic Stroke, Neuroprotection |
Not applicable | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Ischemic Stroke | 1 |
| Neuroprotection | 1 |
| Stroke, Ischemic | 1 |
| Intravascular Thrombosis | 1 |
| Mechanical Thrombectomy | 1 |
| Lead sponsor | Trials |
|---|---|
| Hui-Sheng Chen | 2 |
| Register | Intra-arterial administration of neuroprotective agents trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Intra-arterial administration of neuroprotective agents works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Intra-arterial administration of neuroprotective agents (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.